Assessing the Quality of Life of Caregivers and Before and After the Position of Gastronomy

The goal of this reasearch project is to study the quality of life of caregivers and children with generic questionnaires, validated and used in other pathologies and chronic diseases of the child.

This will allow reproducibility and comparisons to other populations, general or other chronic diseases (acute leukemias ...) This is to conduct a pilot study, preliminary to the construction of a larger study, longitudinal with several evaluation times.

Study Overview

• Status: Unknown
• Conditions: Gastrostomy
• Intervention / Treatment: Other: gastronomy

Detailed Description

Gastrostomy involves creating an opening between the skin and the stomach. It allows the administration of nutrition solutes or food directly into the stomach without passing through the mouth and esophagus. It is a method widely used since the 1980s for enteral nutrition.

In the field of pediatrics, gastrostomy is considered in chronic diseases when enteral nutrition is necessary in the long term. It allows weight gain and improves nutritional status. The percutaneous endoscopic method is nowadays one of the most widespread methods that has proven effective on growth and nutrition, with few side effects .

Few studies have analyzed children's quality of life after gastrostomy. On the one hand, it increases the perceived health of the child after the placement of the caregiver's point of view. It allows a reduction of the stress of the parents, at a distance from the pose, and its insertion would be chosen again by the parents if it were to do again. Meals and medication administration would be easier for parents. But on the other hand, its insertion is often difficult for families to experience, on the one hand by changing the diet . The family dynamics are modified and it would lead to logistical constraints for meals or outings. The vision of the body diagram would also be altered. Following a systematic review of the literature conducted in early 2018, there are currently only 7 longitudinal prospective studies assessing the quality of life of caregivers before and after gastrostomy. No study is French. The numbers are relatively small. All of these studies assess the quality of life of caregivers only, without assessing the quality of life of the child due to age-related constraints and causal pathology. Six of seven studies show an improvement in the quality of life of caregivers after the pose. The 7th study, which is the only multicentre study, shows no improvement in the quality of life, with an increase in time for care and cost. This is a US study in 3 centers comparing 50 children with and without gastrostomy at 3 assessment points at 0, 3 and 6 months. Children with gastrostomy would require more time for care and a cost. This study found no improvement in caregivers' quality of life and mood on a depression scale. However, the 2 groups were not similar in terms of pathology with more hematological pathologies and fewer degenerative neurological pathologies in the group without gastrostomy. The care, devices and materials are paid in the US which is not the case in France and should not impact on the quality of life. These studies, with the exception of 2 who used the SF-36 questionnaire, were conducted with different and non-standardized self-questionnaires.

None of these studies conducted a direct assessment of the child using a questionnaire designed for them. This assessment of children can be performed in children of understanding age and having a pathology that allows them to communicate. It allows an approach and a direct vision of the quality of life. The quality of life of the siblings has also not been studied in these studies whereas it is impacted in the chronic diseases in the brothers and sisters. Our goal is to study the quality of life of caregivers and children with generic questionnaires, validated and used in other pathologies and chronic diseases of the child. This will allow reproducibility and comparisons to other populations, general or other chronic diseases (acute leukemias ...) This is to conduct a pilot study, preliminary to the construction of a larger study, longitudinal with several evaluation times.

• Study Type: Interventional
• Enrollment (Anticipated): 50
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Marseille, France, 13354
    • Recruiting
    • Assistance Publique Hopitaux de Marseille
    • Contact: Alexandre Fabre; Phone Number: 04 91 38 60 40; Email: alexander.fabre@ap-hm.fr
    • Contact: Claire Morando; Phone Number: 04 91 38 29 03; Email: promotion.interne@ap-hm.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 1 month to 17 years (Child)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

Child:

• 1 month to 17 years old;
• Accepting to participate in the study;
• Having a pathology requiring enteral nutrition in the long term exclusive or mixed;
• Having the programming of the insertion of percutaneous gastrostomy in the multidisciplinary pediatric ward.

Helping :

• Parent or representative of the parental authority of a child meeting the inclusion criteria above;
• Accepting to participate in the study;
• Having the ability to comply with the protocol requirements (in particular: understanding and speaking French).
• Siblings:
• 8 to 17 years old;
• Accepting to participate in the study;
• Having the ability to comply with the requirements of the protocol (understanding and speaking French, presenting no sensory, motor, cognitive or severe chronic illness);
• Living in the same home as the sick child.

Exclusion Criteria:

Child:

• Refusing to participate in the study;
• Surgical, radiological or emergency gastrostomy.

Helping :

• Inability to comply with study protocol, or investigator uncertainty about willingness or ability to comply with protocol requirements;
• Refusing to participate in the study.
• Siblings:
• Refusing to participate in the study.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Gastrostomy; Gastrostomy involves creating an opening between the skin and the stomach. It allows the administration of nutrition solutes or food directly into the stomach without passing through the mouth and esophagus. It is a method widely used since the 1980s for enteral nutrition. In the field of pediatrics, gastrostomy is considered in chronic diseases when enteral nutrition is necessary in the long term.

Other: gastronomy; to study the quality of life of caregivers and children with generic questionnaires (13-16), validated and used in other pathologies and chronic diseases of the child. This will allow reproducibility and comparisons to other populations, general or other chronic diseases (acute leukemias ...) This is to conduct a pilot study, preliminary to the construction of a larger study, longitudinal with several evaluation times.; Other Names: investigation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Comparison of the body mass index	Observation of a decrease in body mass index after gastrostomy	19 moths

Collaborators and Investigators

• Sponsor: Assistance Publique Hopitaux De Marseille

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2019
• Primary Completion (Anticipated): July 31, 2020
• Study Completion (Anticipated): October 30, 2020

Study Registration Dates

• First Submitted: June 18, 2019
• First Submitted That Met QC Criteria: July 9, 2019
• First Posted (Actual): July 10, 2019

Study Record Updates

• Last Update Posted (Actual): July 10, 2019
• Last Update Submitted That Met QC Criteria: July 9, 2019
• Last Verified: July 1, 2019

More Information

Terms related to this study

• Other Study ID Numbers: 2018-65; 2018-A03284-51 (Registry Identifier: ANSM)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No